Reckitt Benckiser Group plc (RBGLY)
| Market Cap | 41.99B |
| Revenue (ttm) | 18.11B |
| Net Income (ttm) | 1.95B |
| Shares Out | n/a |
| EPS (ttm) | 2.73 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Aug 5, 2024 |
| Volume | 14,962 |
| Open | 12.18 |
| Previous Close | 12.08 |
| Day's Range | 12.13 - 12.19 |
| 52-Week Range | 10.24 - 15.03 |
| Beta | 0.09 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 25, 2024 |
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet bra... [Read more]
Financial Performance
In 2023, Reckitt Benckiser Group's revenue was 14.61 billion, an increase of 1.07% compared to the previous year's 14.45 billion. Earnings were 1.64 billion, a decrease of -29.48%.
Financial numbers in GBP Financial StatementsNews
TV advertising in news genre up in first half, driven by F&B
Television advertising in the news genre increased by 5% year-on-year during January-June, driven primarily by food and beverages. Cement emerged as the top category with Ultratech Cement leading. Hin...
10 High-Yield A-Rated Blue-Chips For Potentially Scary Times Ahead
The economy is stable but cooling, with the labor market showing signs of slowing down. GDP growth is likely to keep falling, and individual companies could suffer. Long-term investors should focus on...
Abbott Labs Stock Falls After Baby-Formula Ruling. Reckitt Benckiser Tumbles Too.
Shares of Abbott Laboratories and U.K.-listed Reckitt Benckiser both drop after a Missouri jury rules against the American healthcare company.
Baby-formula settlement drags Reckitt down after $495 million jury award against Abbott
U.K. consumer-products giant Reckitt saw its share price slump after a jury awarded $495 million in a key baby-formula case.
Abbott shares slide after trial verdict, weigh on rival Reckitt Benckiser
Abbott Laboratories' shares fell nearly 7% premarket, while British peer Reckitt Benckiser slumped 9% on Monday, after the U.S. healthcare firm was ordered to pay $495 million in damages related to it...
Reckitt Benckiser Group plc (RBGPF) Q2 2024 Earnings Call Transcript
Reckitt Benckiser Group plc (OTCPK:RBGPF) Q2 2024 Results Conference Call July 24, 2024 3:30 AM ET Company Participants Richard Joyce - Head of Investor Relations Kristoffer Licht - CEO & Executive Di...
Reckitt to simplify by dropping home products and troubled infant-formula unit
Reckitt Benckiser Group on Wednesday said it plans to refocus its business on its top-selling brands including Durex and Gaviscon by pulling away from its more troubled and less profitable segments in...
Reckitt to offload homecare brands, consider nutrition options
Reckitt Benckiser will consider options for its troubled nutrition business and offload a portfolio of homecare brands by the end of 2025, it said on Wednesday, planning to refocus on healthcare and h...
Reckitt's baby formula sales to suffer after tornado damages warehouse
Sales of Reckitt's Mead Johnson baby formula powder are likely to take a short-term hit after a tornado damaged a third-party warehouse in the United States, the British consumer goods company said on...
U.K. Top 40 Quality Dividend Stocks: Summer 2024
Unfortunately, UK investors have had to suffer weak or negative capital gains in recent years to get those high yields. The good news is that the UK remains an attractive market for dividend investors...
Top 3 undervalued U.K. stocks that are worth owning in June 2024
FTSE 100 is currently down about 3.5% versus its year-to-date high in last month. But there's a bunch of U.K. stocks that are trading at a much more attractive discount at writing.
Reckitt Benckiser: Attractive Price For Its Stable Of Brands (Rating Upgrade)
Reckitt, a consumer goods producer, has experienced a decline in share price due to concerns over its nutrition business and ongoing legal issues. Despite underwhelming business performance, Reckitt's...
Reckitt Benckiser Group plc (RBGPF) Q1 2024 Earnings Call Transcript
Reckitt Benckiser Group plc (OTCPK:RBGPF) Q1 2024 Earnings Conference Call April 24, 2024 3:30 AM ET
Reckitt beats quarterly like-for-like sales estimates
Consumer goods group Reckitt's like-for-like sales growth beat estimates in the first quarter as more people bought its Lysol, Dettol and Finish cleaning products even as prices rose, it said in a tra...
U.K. Top 40 Quality Dividend Stocks: Q2 2024
The list ranks stocks based on their market cap and dividend yield alone. What I am looking for is quality dividend stocks with long track records of progressive dividend growth, and while dividend yi...
Reckitt Benckiser sees modest bounce following $7.1 billion market-cap wipeout
Reckitt Benckiser saw modest gains on Monday, following the share-price slide that erased some £5.6 billion ($7.1 billion) of market value.
Reckitt says many cases filed against baby formula makers
Reckitt said on Monday that many cases had been filed against baby formula makers in general, but it was unclear how many directly related to its unit's Enfamil product.
Enfamil maker vows to fight $60 million baby-formula verdict
Reckitt Beckinser Group said Friday it will seek to overturn a court ruling this week that awarded $60 million in damages to the family of a baby that died after being fed Enfamil infant formula, made...
Reckitt Benckiser Sheds Nearly $7 Billion in Market Value After Infant-Formula Verdict
The rout came after it was reported that an Illinois jury ordered the company's Mead Johnson unit to pay $60 million in compensation related to the death of a premature baby fed Enfamil.
Reckitt unit hit with $60 million verdict in Enfamil baby formula case in Illinois
An Illinois jury has ordered Reckitt Benckiser unit Mead Johnson to pay $60 million to the mother of a premature baby who died of an intestinal disease after being fed the company's Enfamil baby formu...
International Wide-Moat Stocks On Sale - The March 2024 Heat Map
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of th...
Reckitt Benckiser Group plc (RBGPF) Q4 2023 Earnings Call Transcript
Reckitt Benckiser Group plc (RBGPF) Q4 2023 Earnings Call Transcript
Reckitt Benckiser Profits Hit by Sales Slowdown, Charge
Reckitt Benckiser posted a sharp drop in its profits for 2023, as higher prices failed to offset lower sales, in a “grim” set of results that put the company on course for its sharpest share price dro...
Reckitt posts like-for-like net sales drop as fewer people buy flu medication
Consumer goods group Reckitt missed fourth-quarter like-for-like net sales expectations, it said on Wednesday, citing declining sales of cold and flu season products.
Reckitt Benckiser: Undervalued With Sound Growth Prospects
Shares of Reckitt Benckiser have underperformed in recent years, and they now trade at a meaningful discount to global peers. Performance has been somewhat lumpy due to various one-time, non-company-s...